Език: EN EN
← Назад към резултатите
Набира участници Фаза 3 NCT05878769

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Фаза 3 – широко изпитване преди одобрение
Заболявания: Chronic Obstructive Pulmonary Disease

Спонсор: Hoffmann-La Roche

Налично на: БГ
Обобщение
The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.
Кой може да участва
Inclusion Criteria: * Completion of the 52-week treatment period in either parent GB43311 or GB44332 Exclusion Criteria: * Withdrawal of consent and/or premature discontinuation from parent study * Any permanent discontinuation of study drug in parent study * Significant non-compliance in the parent study, specifically defined as missing scheduled visits, per investigator's judgment * Any new diagnosis of asthma according to the Global Initiative for Asthma guidelines or other accepted guidelines since enrolling in the parent study * Any new clinically significant pulmonary disease other than COPD (e.g., pulmonary fibrosis, sarcoidosis, chronic pulmonary embolism or primary pulmonary hypertension, alpha-1-antitrypsin deficiency) since enrolling in the parent study * Any new unstable cardiac disease, myocardial infarction, or New York Heart Association Class III or IV heart failure since enrolling in the parent study
Места на провеждане 37
Argentina (1)
Centro Medico Capital
La Plata , Buenos Aires
Австралия (1)
Flinders Medical Centre
Bedford Park , South Australia
Белгия (1)
AZ Sint-Jan Brugge-Oostende
Bruges
Бразилия (1)
LMK Servicos Medicos SS
Porto Alegre , Rio Grande do Sul
България (1)
MHAT Knyaginya Klementina Sofia EAD
Sofia , Sofia-Grad
Канада (1)
Edmonton Respiratory Consultants
Edmonton , Alberta
Chile (1)
Centro de Estudios Clinicos
Ñuñoa
Китай (1)
Anhui Chest Hospital
Hefei , Anhui
Чехия (1)
Plicní ambulance MUDr. I. Cierná Peterová s.r.o.
Brandýs nad Labem-Stará Boleslav
Дания (1)
Aalborg Universitetshospital
Aalborg
Франция (1)
Clinique de l'Europe
Amiens
Гърция (1)
Evangelismos General Hospital of Athens
Athens
Hong Kong (1)
Tuen Mun Hospital
Hong Kong
Унгария (1)
Obudai Egeszsegugyi Centrum Kft.-Budapest
Budapest
Индия (1)
Paarthiv Lung Care Center
Hyderabad , Andhra Pradesh
Израел (1)
Assuta Ashdod Medical Center
Ashdod
Италия (1)
Azienda Ospedaliera Dei Colli
Naples , Campania
Япония (1)
Japan Community Health Care Organization Hokkaido Hospital
Toyohira-ku, Sapporo City , Hokkaido
Kenya (1)
KEMRI-MTWAPA Clinical Trial Site
Kilifi
Latvia (1)
Daugavpils Regional Hospital
Daugavpils
Mexico (1)
CICUM San Miguel
Guadalajara , Jalisco
ACTIVE_NOT_RECRUITING
Нидерландия (1)
Meander Medisch Centrum
Amersfoort
New Zealand (1)
P3 Research - Kapiti - PPDS
Waikanae , Wellington Region
Peru (1)
Clinica Providencia (Inverconsult Sociedad Anonima) - PPDS
San Miguel , Lima region
Philippines (1)
Manila Central University-Filemon D Tanchoco Medical Foundation
Caloocan
Полша (1)
Viltis Medica Sp. Z o.o.
Trzebnica , Lower Silesian Voivodeship
Puerto Rico (1)
Allianze Pulmonary Research LLC
Guaynabo
Румъния (1)
Neomed Out-Patient Treatment and Diagnosis Medical Center SRL
Brasov
South Africa (1)
Johese Clinical Research
City of Tshwane , Gauteng
Южна Корея (1)
Soon Chun Hyang University Hospital Bucheon
Bucheon-si
Испания (1)
Hospital de Merida
Mérida , Badajoz
Швеция (1)
Fysikalisk Medicin i Stockholm AB
Lidingö
Taiwan (1)
Changhua Christian Hospital
Chang-hua
Тайланд (1)
Srinagarind Hospital, Khon Kaen University
Khon Kaen
Турция (1)
Cukurova University Medical Faculty Balcali Hospital
Adana
Великобритания (1)
Guys Hospital
London , Middlesex
САЩ (1)
UAB Lung Health Center
Birmingham , Alabama
Технически детайли
Статус
Набира участници
Фаза
Фаза 3
Вид изследване
INTERVENTIONAL
Пол
Мъже и жени
Минимална възраст
40 Years
Максимална възраст
90 Years
Здрави доброволци
Не
Начална дата
28.06.2023
Крайна дата
30.06.2027
Регистрационен номер
NCT05878769
Източник
anzctr
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.